Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1003743

registered interest
date	09/11/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what plans he has to increase the (a) knowledge and (b) awareness among GPs of the benefits of medicinal cannabis.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	189815
answer	answer is ministerial correction date of answer 20/11/2018 answer text <p>The Government has rescheduled cannabis-based products for medicinal use from Schedule 1 to Schedule 2 of the Misuse of Drugs Regulations 2001. Doctors on the specialist register of the General Medical Council may now prescribe these products where there might be potential benefit to individual patients. General practitioners will not be able to prescribe but the Government has commissioned the National Institute for Health and Care Excellence to produce guidance for all clinicians by October 2019.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 20/11/2018 11:38:40 answering member 4067 label Biography information for Steve Brine
tabling member	4623 label Biography information for Tonia Antoniazzi

946807

registered interest
date	23/07/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, with reference to the recommendation of the Advisory Council on the Misuse of Drugs that medicinal cannabis products be moved out of Schedule 1 and into Schedule 2 of the Misuse of Drugs Regulations, how long it will take to reclassify the medicinal cannabis oil used by Alfie Dingley and Billy Caldwell; and whether he plans to ensure that all patients who might benefit from such treatment will be able to access medicinal cannabis by the time the House returns from its summer recess.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	167359
answer	answer is ministerial correction date of answer 07/09/2018 answer text <p>Following the short term ACMD advice, the Home Secretary has confirmed that cannabis-derived medicinal products will be rescheduled. This means that senior clinicians will be able to prescribe the medicines to patients with an exceptional clinical need.</p><p>The Department of Health and Social Care and the Medicines and Healthcare products Regulatory Agency will now develop a clear definition of what constitutes a cannabis-derived medicinal product. Only products meeting this definition will be rescheduled. Other forms of cannabis will be kept under strict controls and will not be available on prescription. We will provide more details about this definition and the kinds of products that will be covered in due course.</p><p>The Home Secretary has been clear that speed is of the essence and the products will be available on prescription in the autumn.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 07/09/2018 18:35:25 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4623 label Biography information for Tonia Antoniazzi

943843

registered interest
date	18/07/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what discussions he is having with NHS England to ensure that consultants are aware of the licensing process for access to medical cannabis.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	165715
answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>The Department is working with NHS England and equivalents in the devolved administrations to ensure that cannabis-based medicinal products are sourced and supplied where a licence is granted. In the longer-term, prescribing guidance will be developed following any decision to reschedule these products.</p><p> </p><p>Guidance on the licensing process for access to cannabis and cannabis-based medicinal products is available on the Home Office Gov.uk website.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/07/2018 15:04:17 answering member 4067 label Biography information for Steve Brine
tabling member	4623 label Biography information for Tonia Antoniazzi

942590

registered interest
date	16/07/2018
answering body	Northern Ireland Office
answering dept id	21
answering dept short name	Northern Ireland
answering dept sort name	Northern Ireland
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Northern Ireland, what discussion she has had with the Department of Health in Northern Ireland the conditions of the licence for Billy Caldwell to ensure the availability of medicinal cannabis without the need to travel to Belfast.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	164518
answer	answer is ministerial correction date of answer 23/07/2018 answer text <p>Northern Ireland Office officials are in regular contact with Department of Health Northern Ireland officials to ensure that, following a recommendation from the expert panel, appropriate licences are in place which allow patients to be treated with cannabis-based medicines.</p><p>It would not be appropriate for me to discuss the specific circumstances of certain individuals.</p><p> </p> answering member constituency North West Cambridgeshire answering member printed Mr Shailesh Vara question first answered 23/07/2018 08:49:05 answering member 1496 label Biography information for Shailesh Vara
tabling member	4623 label Biography information for Tonia Antoniazzi

942648

registered interest
date	16/07/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what guidance his Department has given to the respective health departments in the devolved nations on access to medical cannabis under licence.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	164519
answer	answer is ministerial correction date of answer 20/07/2018 answer text <p>Advice about clinical applications for medicinal cannabis is available on the gov.uk website, which was publicised at the time of the Expert Panel’s launch. This makes clear that applications must be made by senior clinicians who are on the General Medical Council’s relevant specialist register with an active license to practise.</p><p>The Department for Health and Social Care is working with NHS England and equivalents in the devolved nations to ensure that cannabis based medicinal products are sourced and supplied where a licence is granted. In the longer term, prescribing guidance will be developed following any decision to reschedule these products.</p><p> </p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 20/07/2018 13:59:35 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4623 label Biography information for Tonia Antoniazzi

942651

registered interest
date	16/07/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, what discussions he is having with NHS England to ensure that consultants are aware of the licencing process for access to medical cannabis.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	164520
answer	answer is ministerial correction date of answer 20/07/2018 answer text <p>Advice about clinical applications for medicinal cannabis is available on the gov.uk website, which was publicised at the time of the Expert Panel’s launch. This makes clear that applications must be made by senior clinicians who are on the General Medical Council’s relevant specialist register with an active license to practise.</p><p>The Department for Health and Social Care is working with NHS England and equivalents in the devolved nations to ensure that cannabis based medicinal products are sourced and supplied where a licence is granted. In the longer term, prescribing guidance will be developed following any decision to reschedule these products.</p><p> </p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 20/07/2018 14:01:07 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4623 label Biography information for Tonia Antoniazzi

935292

registered interest
date	06/07/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for the Home Department, if he will discuss with the Department of Health in Northern Ireland the conditions of the licence for Billy Caldwell to ensure he can receive medicinal cannabis without having to travel to Belfast.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	161589
answer	answer is ministerial correction date of answer 11/07/2018 answer text <p>This is a devolved matter for the Department of Health in Northern Ireland with whom we work collaboratively. Licence conditions can be individually tailored to fit an individual situation based on assessment of risk and in the interests of safeguarding those who are licensed or indirectly benefit from a licence.</p> answering member constituency Ruislip, Northwood and Pinner answering member printed Mr Nick Hurd question first answered 11/07/2018 15:58:27 answering member 1561 label Biography information for Mr Nick Hurd
tabling member	4623 label Biography information for Tonia Antoniazzi

869408

registered interest
date	22/03/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cannabis: Medical Treatments
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether he plans to grant licences for medicinal cannabis products; and if he will make a statement.
tabling member constituency	Gower
tabling member printed	Tonia Antoniazzi
uin	133922
answer	answer is ministerial correction date of answer 29/03/2018 answer text <p>The Medicines and Healthcare products Regulatory Agency (MHRA) is the United Kingdom Agency responsible for the regulation of medicines used in the UK.</p><p> </p><p>The MHRA has not received any marketing authorisation (licence) applications for a medicinal product that contains raw cannabis, for the treatment of any condition in the UK.</p><p> </p><p>If a licence application for a medicinal product containing raw cannabis is received, the MHRA would assess the data submitted to ensure that the product is safe, has efficacy in the purpose claimed for it, is manufactured to the necessary quality standards and that there is a positive balance of benefits over any risks before approval of the licence.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 29/03/2018 11:18:22 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	4623 label Biography information for Tonia Antoniazzi